Community

Our community narratives are driven by numbers and valuation.

Value any stock for free in seconds

Get alerts and valuation updates

Participate in discussions

Weekly Picks

SILO logo
Silo Pharma
CM
CMCVentures
Community Contributor

Groundbreaking therapies that could change the treatment landscape for PTSD, fibromyalgia, MS & Alzheimer’s

Key Takeaways Silo Pharma is advancing a diversified pipeline of innovative therapies aimed at major health challenges in Central Nervous System (CNS) disorders like PTSD, fibromyalgia, Alzheimer’s, and multiple sclerosis (MS). The company’s unique approach of combining traditional drugs with psychedelic-inspired therapies positions it to address significant gaps in the treatment landscape.
View narrative
US$6.20
FV
86.8% undervalued intrinsic discount
234.00%
Revenue growth p.a.
6users have liked this narrative
0users have commented on this narrative
17users have followed this narrative
7 days ago author updated this narrative
DOCN logo
DigitalOcean Holdings
NE
Nenad
Community Contributor

DigitalOcean Will Grow 14% by Embracing AI with Paperspace Acquisition

1. Current Business (Present Narrative): DigitalOcean is a cloud computing provider focused on small and medium-sized businesses (SMBs) , startups, and developers.
View narrative
US$50.00
FV
43.5% undervalued intrinsic discount
18.62%
Revenue growth p.a.
1users have liked this narrative
0users have commented on this narrative
12users have followed this narrative
4 months ago author updated this narrative

Community Investing Ideas

Load previous narratives
WIZC3 logo
Wiz Co Participações e Corretagem de Seguros
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts

Digital Technology And Diversification Will Improve Operational Performance

Key Takeaways Investment in Wiz Pro platform and product diversification aims to boost revenue and engage a broader customer base. Debt restructuring and fiscal discipline target enhanced profitability and potential shareholder returns.
View narrative
R$8.67
FV
31.8% undervalued intrinsic discount
-2.77%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
6users have followed this narrative
6 days ago author updated this narrative
CEU logo
CES Energy Solutions
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts

Expansion Into Permian Basin And Haynesville Will Strengthen Future Prospects

Key Takeaways Strategic tuck-in acquisitions and market share growth in key areas are set to enhance CES's revenue and market position. Focused expansion and infrastructure investments aim to capture growth opportunities and improve operational efficiencies.
View narrative
CA$10.16
FV
40.8% undervalued intrinsic discount
3.81%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
14users have followed this narrative
6 days ago author updated this narrative
DANHOS 13 logo
Fibra Danhos
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts

Cuautitlán II And Palomas Expansion Will Secure Future Stability

Key Takeaways Expansion in high-demand logistics areas and strong retail lease spreads are expected to boost future revenue and improve earnings. Strong balance sheet with low leverage and high credit rating allows favorable refinancing, supporting growth and improved net margins.
View narrative
Mex$24.31
FV
6.2% undervalued intrinsic discount
8.86%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
6 days ago author updated this narrative
LIVN logo
LivaNova
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts

Investment In Obstructive Sleep Apnea And DTD Therapies Will Strengthen Future Market Position

Key Takeaways Strategic focus on obstructive sleep apnea and cardiopulmonary advancements is key for revenue growth and market expansion. Operational efficiency through talent transformation and R&D investment aims to diversify revenue streams and improve margins.
View narrative
US$59.90
FV
41.3% undervalued intrinsic discount
4.87%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
6 days ago author updated this narrative
SFOR logo
S4 Capital
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts

Restructuring, AI Services And NVIDIA Partnership Will Transform Operations

Key Takeaways Restructuring efforts and improved operational efficiency aim to boost margins and drive increased profitability for S4 Capital. AI-driven services and strategic client wins enhance revenue growth through innovation and expanded market engagements.
View narrative
UK£0.53
FV
48.8% undervalued intrinsic discount
-0.70%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
6 days ago author updated this narrative